Aegon Shareholders Approve US Redomiciliation as UK Business Moves to Standard Life

Key Points

• Aegon shareholders have approved the group’s proposed redomiciliation to the United States, clearing a major corporate governance hurdle for the company’s transition to Delaware.
• The Dutch-founded insurance group plans to operate under the name Transamerica Inc., reflecting its strategic focus on the US life insurance and retirement markets.
• The company’s UK business, which serves approximately 3.8 million customers through workplace pension and adviser platforms, is being sold to Standard Life.
• The sale of Aegon UK was agreed in April 2026 following a strategic review initiated after the US restructuring plans were announced in December 2025.
• Aegon UK’s operations are expected to continue without changes to products, platforms or service standards while the acquisition remains pending.
• Aegon Asset Management is excluded from the UK sale and will remain part of the wider group, continuing as an asset management partner to the combined Standard Life and Aegon UK business.
• Aegon expects to repurchase the Class B common shares held by Vereniging Aegon on 15 October 2026, replacing them with shares carrying equal voting rights on a 40-to-1 basis.
• Vereniging Aegon is expected to retain an approximately 18.4% stake and become known as Vereniging Aegon Americas.
• The New York Stock Exchange is expected to become Aegon’s primary listing venue, while a listing on Euronext Amsterdam will be retained for the time being.
• The group plans to become a US tax resident, adopt US generally accepted accounting principles (US GAAP) and complete its transition by January 2028.
• Chief executive Lard Friese is expected to relocate to the United States at the beginning of 2027.
• The redomiciliation is not expected to affect the operational arrangements or completion timetable of the Standard Life transaction.

Britain Post News (BPN) October 9, 2026 – Aegon shareholders have approved the insurance group’s plan to redomicile in the United States, advancing a restructuring that will see the company adopt the Transamerica Inc. name and focus more closely on the American life insurance and retirement markets. The decision follows the agreement to sell Aegon’s UK business to Standard Life, marking a significant change in the group’s position in the British pensions and investment platform market. While the US corporate transition will reshape Aegon’s legal, financial reporting and regulatory arrangements, the immediate priority for UK advisers remains the transition of the business serving approximately 3.8 million customers to new ownership.

The shareholder vote establishes the corporate direction, while the Standard Life acquisition remains the principal development for UK advisers and pension customers. Aegon has said the redomiciliation will not change the operational position of its UK business or determine the timetable for the proposed sale.

What does Aegon’s shareholder approval mean for its US restructuring?

According to the report published by Insurance Business UK, shareholders approved the redomiciliation proposal and an omnibus incentive plan at an extraordinary general meeting. The decision gives the company the mandate to proceed with the planned restructuring of its corporate domicile, headquarters and shareholder arrangements.

The move forms part of a broader strategic shift towards the United States, where Aegon already conducts most of its business through Transamerica.

The company announced its intentions at its Capital Markets Day in December 2025. Its stated objective was to sharpen its focus on the US life insurance and retirement market, which has become central to the group’s operations.

According to Aegon’s shareholder materials filed with the US Securities and Exchange Commission, Transamerica represents approximately 80% of the group’s operations. The proposed restructuring is therefore intended to align the group’s legal and corporate arrangements more closely with the market that accounts for most of its activities.

Under the approved plan, Aegon will continue as Transamerica Inc., incorporated in Delaware. The company intends to retain its existing legal personality while converting its current common shares into Transamerica stock.

The decision represents more than a change of corporate name. It will affect the group’s tax residency, financial reporting framework, stock market arrangements and regulatory supervision.

However, the distinction between corporate restructuring and day-to-day operations remains important. The redomiciliation is not itself an operational merger of Aegon’s UK business with Standard Life, nor does it immediately change the products and services currently provided to UK customers.

Why is Aegon selling its UK business to Standard Life?

Aegon agreed to sell Aegon UK to Standard Life in April 2026 following a strategic review that began after the company announced its planned move to the United States.

The transaction represents a separate but closely related element of the group’s wider restructuring. While the redomiciliation aligns Aegon’s corporate structure with its American operations, the UK sale changes the ownership outlook for its British workplace pension and adviser platform businesses.

Aegon UK serves approximately 3.8 million customers through its workplace and adviser platforms. Its operations form part of the UK pensions and long-term savings market, where advisers, employers and individual customers rely on investment platforms and pension administration services.

According to the Insurance Business UK report, Aegon UK is now accounted for as a business held for sale and no longer contributes to the group’s operating result. This accounting treatment reflects the intended disposal rather than indicating that the UK operation has already transferred to Standard Life.

The transaction remains a significant consideration for advisers who recommend Aegon products or manage clients’ pension arrangements through its platforms.

For those advisers, the key issue is not the corporate name adopted by the parent company in the United States. It is how the UK business will operate once the acquisition completes, including whether its existing products, investment options, charges, technology and service arrangements will remain unchanged or be integrated into Standard Life’s wider offering.

The available information does not establish a complete timetable for any future platform integration or confirm specific changes to customer terms. Those matters will depend on the transaction’s progress and subsequent decisions by the businesses involved.

Will Aegon UK customers experience changes before the sale completes?

Aegon has indicated that its UK business will continue serving advisers and their clients while the sale to Standard Life remains pending.

The company has stated that there will be no changes to products, platforms or service standards during this period. This means customers and advisers should continue to use the existing arrangements unless the business communicates otherwise.

The distinction is important because a change in the parent company’s corporate domicile does not automatically change the contracts, services or administrative arrangements of a separate operating business.

Aegon’s planned move to Delaware and New York is a group-level development. The Standard Life transaction is the event directly relevant to the future ownership of the UK operation.

For pension savers, continuity of administration and access to information will remain important throughout the transition. Customers may need to monitor communications about any future changes, but the announcement does not provide grounds to conclude that immediate alterations to their pension arrangements are planned.

Advisers should also distinguish between confirmed developments and matters that remain undecided. The sale agreement establishes the intended direction of travel, but specific integration decisions should not be assumed before they are formally communicated.

The position of Aegon’s UK insurance entity will also remain relevant. Scottish Equitable plc is Aegon UK’s primary insurance entity, and its financial strength is an important consideration when advisers assess the underlying provider supporting insurance and pension-related commitments.

Aegon’s half-year results indicated that Scottish Equitable’s Solvency UK ratio remained above its operating level. However, advisers will need to assess subsequent disclosures to understand how the entity’s capital position develops through the transition and under any eventual new ownership arrangements.

What will happen to Aegon’s shares and Vereniging Aegon?

Aegon expects to repurchase all Class B common shares held by its largest shareholder, Vereniging Aegon, on 15 October 2026.

Under the announced arrangement, those shares will be exchanged for common shares carrying equal voting rights on a 40-to-1 basis. Interim bye-laws approved at the extraordinary general meeting are expected to take effect at that point.

The transaction will alter the shareholder structure as the company moves towards its new US corporate identity.

Vereniging Aegon will be renamed Vereniging Aegon Americas and is expected to retain an approximately 18.4% stake in the company. It will therefore continue to hold a significant shareholding after the restructuring.

The changes also address the future of the organisation’s charitable activities in the Netherlands.

According to the company’s announced plans, its Dutch charitable activities will continue through a newly established foundation, Stichting Aegon Fonds Nederland. This arrangement separates the continuation of those activities from the changes to the parent company’s corporate domicile and shareholder structure.

The shareholder arrangements form part of the legal and governance preparations required to implement the redomiciliation.

The planned exchange of shares, changes to the company’s bye-laws and continued stake held by Vereniging Aegon are intended to establish the ownership framework for Transamerica Inc. once the transition takes effect.

The precise financial implications for individual investors will depend on the final implementation of the arrangements and the applicable disclosures. The announcement should not, on its own, be interpreted as a prediction of future share-price performance.

Why is New York becoming Aegon’s corporate headquarters?

Aegon selected New York City as its corporate headquarters in June 2026, according to a filing with the US Securities and Exchange Commission.

The decision supports the company’s wider plan to establish a more US-centred corporate structure.

Under the proposed arrangements, the New York Stock Exchange is expected to become the group’s primary listing venue. Aegon also expects to retain a listing on Euronext Amsterdam for the time being, preserving a connection with its existing European investor base.

The headquarters decision is also expected to affect senior management arrangements. Chief executive Lard Friese is due to relocate to the United States at the beginning of 2027.

These changes are consistent with Aegon’s stated intention to focus on its American life insurance and retirement operations.

Nevertheless, the shift in corporate headquarters does not mean the group will immediately withdraw from every European activity. The retention of Aegon Asset Management and its continued role in supporting the combined Standard Life and Aegon UK business demonstrate that the company expects to preserve certain operations and commercial relationships outside the United States.

The continuing Euronext Amsterdam listing also indicates that the company intends to maintain access to European capital markets during the transition, at least in the near term.

The extent to which the move changes investor participation, trading patterns or the company’s relationship with European markets will depend on how the new arrangements operate after implementation.

How will Aegon’s tax residency and financial reporting change?

The redomiciliation will introduce changes to Aegon’s tax residency and accounting framework.

The company plans to become a US tax resident and transition from International Financial Reporting Standards (IFRS) to US generally accepted accounting principles (US GAAP).

The new reporting framework is expected to apply from Aegon’s full-year 2027 results. The company has said it expects the overall transition to be completed by January 2028.

The change is significant because accounting standards influence how insurers present financial performance, assets, liabilities and other measures in their published results.

IFRS and US GAAP are distinct accounting frameworks. Moving between them can affect how financial information is classified and presented, meaning investors and analysts may need to account for differences when comparing results across reporting periods.

However, a change in accounting standards does not automatically demonstrate that a company’s underlying commercial performance has improved or deteriorated. Investors will need to distinguish between changes arising from reporting methodology and changes resulting from actual business performance.

Aegon’s planned shift in tax residency is another component of the restructuring. The final financial consequences will depend on the applicable rules and the company’s circumstances under the new arrangements.

The company’s transition schedule indicates that the process will extend beyond the shareholder vote. Preparations will be required across financial reporting, corporate administration, governance and regulatory arrangements before the new structure is fully implemented.

How will US redomiciliation affect Aegon’s regulatory supervision?

Aegon has indicated that the lead regulator and scope of group supervision will be reassessed by the relevant authorities when the redomiciliation takes place.

The company also expects to move away from a consolidated solvency view towards entity-based capital ratios and ratings, an approach typically used by US insurers.

This is an important distinction for investors and stakeholders assessing the financial position of an insurance group.

A consolidated solvency assessment considers the group’s capital position on a combined basis, while entity-based measures place greater emphasis on the financial position of individual legal entities. The two approaches can provide different perspectives on where capital is held and which entities support particular insurance obligations.

The change does not, by itself, establish that Aegon’s capital position will strengthen or weaken. Its significance will depend on the requirements applied by regulators, the capital held by individual entities and the disclosures available under the new framework.

For advisers working with Aegon UK products, the immediate implications of the group-level regulatory changes are expected to be limited compared with those arising from the proposed sale to Standard Life.

Nevertheless, financial strength remains relevant when advisers assess insurers and long-term savings providers. They will need to review the applicable financial disclosures and any material changes communicated during the transition.

The regulatory arrangements for the US parent company should also be distinguished from the requirements applicable to UK entities. The redomiciliation does not automatically remove the need for UK insurance operations to meet relevant domestic regulatory obligations.

What should UK financial advisers monitor during the transition?

For UK advisers, the shareholder vote reinforces the direction established by the proposed sale of Aegon UK to Standard Life.

The most immediate practical questions concern continuity, service delivery and the eventual integration of the UK business.

Advisers should monitor formal communications from both companies about the transaction’s completion, any changes to platform administration and the treatment of existing products. They should also review information about investment choices, charges and client servicing if any changes are announced.

Where advisers recommend products issued by Scottish Equitable plc, they should continue to consider the insurer’s financial position and relevant solvency disclosures rather than assuming that the parent company’s restructuring determines the subsidiary’s financial strength.

The continued role of Aegon Asset Management also deserves attention. The asset management business is excluded from the sale and is expected to remain an investment partner to the combined Standard Life and Aegon UK business after completion.

That relationship could be relevant to advisers seeking to understand the future investment arrangements available through the platform business. However, the announcement does not confirm that every existing fund, investment option or commercial arrangement will remain unchanged indefinitely.

The appropriate approach is therefore to distinguish confirmed continuity commitments from future arrangements that have not yet been announced.

Advisers should also communicate carefully with clients. The US redomiciliation and the UK business sale are related strategic developments, but they are not the same transaction. Explaining that distinction can help prevent customers from confusing a change in the parent company’s domicile with an immediate change to their own pension arrangements.

What is the background to Aegon’s corporate restructuring?

Aegon’s restructuring follows a strategic review announced alongside its plans to strengthen its focus on the US life insurance and retirement market in December 2025.

The group’s decision to pursue a US redomiciliation reflects the importance of Transamerica within its existing operations. According to Aegon’s shareholder materials, the US business accounts for approximately 80% of the group’s operations.

The subsequent decision to sell Aegon UK to Standard Life represents a major change in the group’s position in the British retail pensions and adviser platform market.

Aegon UK serves approximately 3.8 million customers, making the proposed transaction relevant to a substantial number of pension savers, workplace schemes and financial advisers.

The sale does not include Aegon Asset Management, which will remain within the group and is expected to continue supporting the combined Standard Life and Aegon UK business following completion.

The restructuring also involves changes to the group’s headquarters, share structure, tax residency, accounting standards and regulatory supervision. These measures are intended to align the corporate framework more closely with its principal US operations.

The shareholder approval represents an important step in that process, but implementation still involves the scheduled share exchange, the adoption of new corporate arrangements and the transition to the planned reporting and regulatory framework.

For the UK market, the central development is the planned transfer of Aegon UK to Standard Life. For the wider group, the move to Transamerica Inc. represents a broader reorganisation of its corporate identity and operating framework.

How could the changes affect UK pension customers, advisers and investors?

The likely effects will differ according to the audience and the stage of the transition.

For UK pension customers, the immediate position is expected to remain stable while the Standard Life transaction is pending. Aegon has stated that its UK business will continue operating without changes to products, platforms or service standards during this period. Customers should rely on formal communications for confirmation of any subsequent changes rather than assuming that the US restructuring will alter their existing arrangements.

For financial advisers, the principal consideration will be the future operation of the UK platform business under Standard Life. Advisers will need to assess any confirmed changes to charges, product availability, investment options, administration and client servicing. The financial strength of relevant insurance entities will also remain important when making recommendations.

For workplace pension schemes and employers, the transition could require attention to future provider communications and any confirmed changes to administration or servicing arrangements. However, no specific changes to scheme terms or operational procedures have been established by the shareholder vote alone.

For Aegon shareholders, the transition will change the company’s corporate domicile, shareholder arrangements, expected primary listing and financial reporting framework. Investors will need to consider the implications of the new structure and account for differences between IFRS and US GAAP when comparing reported results across periods.

For the UK pensions market, the sale will transfer a major platform and workplace pensions business to Standard Life if the transaction completes. The longer-term effects will depend on how the combined business is managed and whether future integration decisions change the services available to customers and advisers.